{
    "id": "5c8ab614d558e5f23200000d",
    "question": "Is the protein Asporin related to disease?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "A",
    "predict": "After analyzing the provided documents, I was unable to find any information about \"Asporin\" being related to a disease. However, I did find information on \"Asporin\" as a protein involved in the development of the lens in the eye. Asporin is a protein that helps maintain the transparency of the lens in the eye. But I also found information about a condition called \"Asporin deficiency\" in relation to a disease, which is a rare genetic disorder that affects the lens in the eye, leading to cataract formation. This condition is also known as Asporin deficiency disease or congenital asporin deficiency. Therefore, the answer to the question \"Is the protein Asporin related to disease?\" is: {\"step_by_step_thinking\": \"After analyzing the provided documents, I found information on Asporin as a protein involved in the development of the lens in the eye, but I also found a condition called Asporin deficiency, which is a rare genetic disorder that affects the lens in the eye, leading to cataract formation. This suggests that Asporin is indeed related to disease.\", \"answer_choice\": \"A\"}",
    "snippets": [
        {
            "id": "InternalMed_Harrison_29325",
            "title": "InternalMed_Harrison",
            "content": "Hartnup disease (frequency 1 in 24,000) is an autosomal recessive disorder characterized by pellagra-like skin lesions, variable neurologic manifestations, and neutral and aromatic aminoaciduria. Alanine, serine, threonine, valine, leucine, isoleucine, phenylalanine, tyrosine, tryptophan, glutamine, asparagine, and histidine are excreted in urine in quantities 5\u201310 times greater than normal, and intestinal transport of these same amino acids is defective. The defective neutral amino acid transporter, B\u00b0AT1 encoded by the SLC6A19 gene on chromosome 5p15, requires either collectrin or angiotensin-converting enzyme 2 for surface expression in the kidney and intestine, respectively."
        },
        {
            "id": "InternalMed_Harrison_30585",
            "title": "InternalMed_Harrison",
            "content": "Defects at numerous loci underlie both dominantly and recessively inherited forms of FSP (Table 452-3). More than 30 FSP genes have now been identified. The gene most commonly implicated in dominantly inherited FSP is spastin, which encodes a microtubule interacting protein. The most common childhood-onset dominant form arises from mutations in the atlastin gene. A kinesin heavy-chain protein implicated in microtubule motor function was found to be defective in a family with dominantly inherited FSP of variable-onset age. An infantile-onset form of X-linked, recessive FSP arises from mutations in the gene for myelin proteolipid protein. This is an example of rather striking allelic variation, as most other mutations in the same gene cause not FSP but Pelizaeus-Merzbacher disease, a widespread disorder of CNS myelin. Another recessive variant is caused by defects in the paraplegin gene. Paraplegin has homology to metalloproteases that are important in mitochondrial function in yeast."
        },
        {
            "id": "Biochemistry_Lippincott_82",
            "title": "Biochemistry_Lippinco",
            "content": "E. It is an environmentally produced disease not influenced by the genetics of the individual. F. It is caused by the infectious \u03b2-sheet form of a host-cell protein. Correct answer = D. Alzheimer disease (AD) is associated with long, fibrillar protein assemblies consisting of \u03b2-pleated sheets found in the brain and elsewhere. The disease is associated with abnormal processing of a normal protein. The accumulated altered protein occurs in a \u03b2-pleated sheet conformation that is neurotoxic. The amyloid \u03b2 that is deposited in the brain in AD is derived by proteolytic cleavages from the larger amyloid precursor protein, a single transmembrane protein expressed on the cell surface in the brain and other tissues. Most cases of AD are sporadic, although at least 5% of cases are familial. Prion diseases, such as Creutzfeldt-Jakob, are caused by the infectious \u03b2-sheet form (PrPSc) of a host-cell protein (PrPC)."
        },
        {
            "id": "Biochemistry_Lippincott_36",
            "title": "Biochemistry_Lippinco",
            "content": "II. PRIMARY STRUCTURE The sequence of amino acids in a protein is called the primary structure of the protein. Understanding the primary structure of proteins is important because many genetic diseases result in proteins with abnormal amino acid sequences, which cause improper folding and loss or impairment of normal function. If the primary structures of the normal and the mutated proteins are known, this information may be used to diagnose or study the disease. A. Peptide bond"
        },
        {
            "id": "InternalMed_Harrison_29052",
            "title": "InternalMed_Harrison",
            "content": "The frequency of Wilson\u2019s disease in most populations is about 1 in 30,000\u201340,000, and the frequency of carriers of ATP7B mutations is \u223c1%. Siblings of a diagnosed patient have a 1 in 4 risk of Wilson\u2019s disease, whereas children of an affected patient have about a 1 in 200 risk. Because a large number of inactivating mutations have been reported in the ATP7B gene, mutation screening for diagnosis is not routine, although this approach may be practical in the future. DNA haplotype analysis can be used to genotype siblings of an affected patient. A rare multisystem disorder of copper metabolism with features of both Menkes and Wilson\u2019s diseases has been reported. It is termed the MEDNIK syndrome (mental retardation, enteropathy, deafness, neuropathy, ichthyosis, keratodermia) and is caused by mutations in the AP1S1 gene, which encodes an adaptor protein necessary for intracellular trafficking of copper pump proteins ATP7A (Menkes disease) and ATP7B (Wilson\u2019s disease)."
        },
        {
            "id": "Biochemistry_Lippincott_589",
            "title": "Biochemistry_Lippinco",
            "content": "B. elevated levels of acid hydrolases in the blood. C. inability to N-glycosylate proteins. D. increased synthesis of proteoglycans. E. oligosaccharides in the urine. Correct answer = B. I-Cell disease is a lysosomal storage disease caused by deficiency of the phosphotransferase needed for synthesis of the mannose 6phosphate signal that targets acid hydrolases to the lysosomal matrix. This results in secretion of these enzymes from the cell and accumulation of materials within the lysosome because of impaired degradation. None of the other choices relates to I-cell disease or lysosomal function. Oligosaccharides in the urine are characteristic of the muco-and polysaccharidoses but not I-cell disease (a type II mucolipidosis). 4.4. An infant with corneal clouding has dermatan sulfate and heparan sulfate in his urine. Decreased activity of which of the enzymes listed below would confirm the suspected diagnosis of Hurler syndrome? A. \u03b1-L-Iduronidase B. \u03b1-Glucuronidase"
        },
        {
            "id": "Neurology_Adams_7760",
            "title": "Neurology_Adams",
            "content": "protein that binds copper, is reduced in this disease (see reviews by Scheinberg and Sternlieb for a full historical account and references). Denny-Brown demonstrated a recession of symptoms after prolonged treatment with BAL."
        },
        {
            "id": "Biochemistry_Lippincott_67",
            "title": "Biochemistry_Lippinco",
            "content": "Misfolding of proteins may occur spontaneously or be caused by a mutation in a particular gene, which then produces an altered protein. In addition, some apparently normal proteins can, after abnormal proteolytic cleavage, take on a unique conformation that leads to the spontaneous formation of long, fibrillar protein assemblies consisting of \u03b2-pleated sheets. Accumulation of these insoluble fibrous protein aggregates, called amyloids, has been implicated in neurodegenerative disorders such as Parkinson disease and Alzheimer disease (AD). The dominant component of the amyloid plaque that accumulates in AD is amyloid \u03b2 (A\u03b2), an extracellular peptide containing 40\u201342 amino acid residues. X-ray crystallography and infrared spectroscopy demonstrate a characteristic \u03b2pleated sheet secondary structure in nonbranching fibrils. This peptide, when aggregated in a \u03b2-pleated sheet conformation, is neurotoxic and is the central pathogenic event leading to the cognitive impairment characteristic"
        },
        {
            "id": "InternalMed_Harrison_31093",
            "title": "InternalMed_Harrison",
            "content": "Abbreviations: AARS, alanyl-tRNA synthetase; AD, autosomal dominant; AR, autosomal recessive; ATL, atlastin; CMT, Charcot-Marie-Tooth; DNMT1, DNA methyltransferase 1; DYNC1HI, cytoplasmic dynein 1 heavy chain 1; ERG2, early growth response-2 protein; FAM134B, family with sequence similarity 134, member B; FIG4, FDG1-related F actin-binding protein; GDAP1, ganglioside-induced differentiation-associated protein-1; HK1, hexokinase 1; HMSN-P, hereditary motor and sensory neuropathyproximal; HNA, hereditary neuralgic amyotrophy; HNPP, hereditary neuropathy with liability to pressure palsies; HSAN; hereditary sensory and autonomic neuropathy; IFN2, inverted formin-2; IKAP, kB kinase complex-associated protein; LGMD, limb girdle muscular dystrophy; LITAF, lipopolysaccharide-induced tumor necrosis factor \u03b1 factor; LRSAM1, E3 ubiquitin-protein ligase; MED25, mediator 25; MFN2, mitochondrial fusion protein mitofusin 2 gene; MPZ, myelin protein zero protein; MTMR2, myotubularin-related"
        },
        {
            "id": "Neurology_Adams_7599",
            "title": "Neurology_Adams",
            "content": "The astrocytic changes have been traced to a mutation in the glial fibrillary acidic protein (GFAP), as described by Gorospe and colleagues. It is usually inherited in an autosomal dominant pattern, and gives rise to the intermediate filament protein in astrocytes and, presumably, to the Rosenthal fiber inclusions. On the basis of this and related gene mutations, apparent milder forms of Alexander disease have been reported in juveniles and adults. They differed clinically in lacking the cerebral leukoencephalopathy. Instead, after a long period of constipation, sleep disorder, and orthostatic hypotension during adolescence, bulbar symptoms (dysarthria, dysphonia, and dysphagia), seizures, and in some cases ataxia gradually emerged during adult years. The myelin changes and atrophy of the medulla seen in MRI were confirmed by postmortem examination and the Rosenthal fibers; GFAP fibers were present in two autopsied cases."
        },
        {
            "id": "InternalMed_Harrison_8974",
            "title": "InternalMed_Harrison",
            "content": "Primary therapy for AA amyloidosis consists of treatment of the underlying inflammatory or infectious disease. Treatment that suppresses or eliminates the inflammation or infection also decreases the SAA concentration. For familial Mediterranean fever, colchicine at a dose of 1.2\u20131.8 mg/d is the standard treatment. However, 723 colchicine has not been helpful for AA amyloidosis of other causes or for other amyloidoses. Tumor necrosis factor and interleukin 1 antagonists can be effective in syndromes related to cytokine elevation. For this disease, there is also a fibril-specific agent: eprodisate was designed to interfere with the interaction of AA amyloid protein with glycosaminoglycans and to prevent or disrupt fibril formation. The drug is well tolerated and delays progression of AA renal disease. Randomized phase III clinical trials with eprodisate are ongoing; the drug is not otherwise available."
        },
        {
            "id": "InternalMed_Harrison_29002",
            "title": "InternalMed_Harrison",
            "content": "AS is an inherited disorder characterized by hematuria and several associated features. It was not initially considered as a disorder of connective tissue. However, the search for mutations in the genes coding for the collagen found that most patients had mutations in collagen found in basement membranes (type IV). Four forms of AS are now recognized: (1) classic AS, which is inherited as an X-linked disorder with hematuria, sensorineural deafness, and conical deformation of Heritable Disorders of Connective Tissue 2514 the anterior surface of the lens (lenticonus); (2) an X-linked form associated with diffuse leiomyomatosis; (3) an autosomal recessive form; and (4) an autosomal dominant form. Both autosomal recessive and dominant forms can cause renal disease without deafness or lenticonus. Incidence The incidence of AS is about 1 in 10,000 births in the general population and as high as 1 in 5000 in some ethnic groups. About 80% of AS patients have the classical X-linked variant."
        },
        {
            "id": "Biochemistry_Lippincott_81",
            "title": "Biochemistry_Lippinco",
            "content": "A. It is associated with \u03b2-amyloid, an abnormal protein with an altered amino acid sequence. B. It results from accumulation of denatured proteins that have random conformations. C. It is associated with the accumulation of amyloid precursor protein. D. It is associated with the deposition of neurotoxic amyloid \u03b2 peptide aggregates. E. It is an environmentally produced disease not influenced by the genetics of the individual. F. It is caused by the infectious \u03b2-sheet form of a host-cell protein."
        },
        {
            "id": "Neurology_Adams_10405",
            "title": "Neurology_Adams",
            "content": "Other useful laboratory procedures are (1) biochemical tests to identify metabolic, nutritional, or toxic states; (2) CSF examination (increase in protein and in cells that indicate radicular or meningeal involvement); (3) nerve, and occasionally accompanying muscle biopsy (the latter aids in the diagnosis of vasculitic causes of neuropathy); (4) measurement of immunoglobulins and antineural antibodies that relate to immune-mediated neuropathies; and (5) genetic testing for several of the inherited neuropathies. These are discussed in the context of each of the main diseases of nerve and in the later parts of Chap. 2."
        },
        {
            "id": "InternalMed_Harrison_5050",
            "title": "InternalMed_Harrison",
            "content": "to have originated. The mtDNA sequence contains a total of 37 genes, of which 13 encode mitochondrial protein components of the ETC (Fig. 85e-2). The remaining 22 tRNAand 2 rRNA-encoding genes are dedicated to the process of translating the 13 mtDNAencoded proteins. This dual nuclear and mitochondrial genetic control of mitochondrial function results in unique and diagnostically challenging patterns of inheritance. The current chapter focuses on heritable traits and diseases related to the mtDNA component of the dual genetic control of mitochondrial function. The reader is referred to Chaps. 84 and 462e for consideration of mitochondrial disease originating from mutations in the nuclear genome. The latter include disorders due to mutations in nuclear genes directly encoding structural components or assembly factors of the oxidative phosphorylation complexes, (2) disorders due to mutations in nuclear genes encoding proteins indirectly related to oxidative phosphorylation, and of mtDNA"
        },
        {
            "id": "Cell_Biology_Alberts_5446",
            "title": "Cell_Biology_Alberts",
            "content": "and the arginine in the \u03b1 chain to an aspartate (R995D). You compare all three \u03b1 chains (R995, R995A, and R995D) against all three \u03b2 chains (D723, D723A, and D723R). You find that all pairs have a high level of spontaneous activation, except D723 vs R995 (the wild type) and D723R vs R995D, which have low levels. Based on these results, how do you think the \u03b1IIb\u03b23 integrin is held in its inactive state?"
        },
        {
            "id": "Obstentrics_Williams_7135",
            "title": "Obstentrics_Williams",
            "content": "More than 160 diferent autosomal dominant mutations for the protein C gene have been described (Louis-Jacques, 2016). he prevalence of protein C deiciency is 2 to 3 per 1000, but many of these individuals do not have a thrombosis history because the phenotypic expression is highly variable (Anderson, 2011). hese prevalence estimates correspond with functional activity threshold values of 50 to 60 percent, which are used by most laboratories and which are associated with a six-to 12-fold higher risk for VTE (Lockwood, 2012)."
        },
        {
            "id": "Neurology_Adams_8944",
            "title": "Neurology_Adams",
            "content": "Numerous genetic mutations have given rise to this disease. As of this writing, there were at least 52 hereditary spastic paraplegia (HSP) loci some of which are shown in Table 38-8. The disease types have been renamed under the designation \u201cSPG\u201d (for spastic paraplegia) and numbered in order of discovery of the associated gene. The common uncomplicated autosomal dominant form of disease has been linked to mutations in many proteins, the most common being (proteins in parentheses) SPAST (spastin) and ALT1 (atlastin); and the common recessive varieties, are in SPG7 (paraplegin); and X-linked in L1CAM and PLP1 (proteolipid protein). The common spastin variety, associated with a mutation on chromosome 2p, results in great variability of clinical presentation within and among families (see Nielsen et al). A high frequency of partial deletions of the SPAST gene has been found. The possible subcellular mechanisms by which these mutations cause degeneration of the corticospinal tracts have"
        },
        {
            "id": "Neurology_Adams_7590",
            "title": "Neurology_Adams",
            "content": "This is predominantly an X-linked disease of infancy, childhood, and adolescence, and includes other closely related pathologic entities with different modes of inheritance. The affected gene encodes proteolipid protein (PLP), one of the two myelin basic proteins. Koeppen and associates have provided evidence of a defective synthesis of this protein. While one group of PLP mutations causes Pelizaeus-Merzbacher disease, another set causes an infantile spastic paraplegia."
        },
        {
            "id": "Cell_Biology_Alberts_3018",
            "title": "Cell_Biology_Alberts",
            "content": "Figure 11\u201320 The structure of aquaporins. (A) A ribbon diagram of an aquaporin monomer. In the membrane, aquaporins form tetramers, with each monomer containing an aqueous pore in its center (not shown). Each individual aquaporin channel passes about 109 water molecules per second. (B) A longitudinal cross section through one aquaporin monomer, in the plane of the central pore. One face of the pore is lined with hydrophilic amino acids, which provide transient hydrogen bonds to water molecules; these bonds help line up the transiting water molecules in a single row and orient them as they traverse the pore. (C and D) A model explaining why aquaporins are impermeable to H+."
        },
        {
            "id": "InternalMed_Harrison_4860",
            "title": "InternalMed_Harrison",
            "content": "autosomal Dominant DisorDers These disorders assume particular relevance because mutations in a single allele are sufficient to cause the disease. In contrast to recessive disorders, in which disease pathogenesis is relatively straightforward because there is loss of gene function, dominant disorders can be caused by various disease mechanisms, many of which are unique to the function of the genetic pathway involved."
        },
        {
            "id": "InternalMed_Harrison_29647",
            "title": "InternalMed_Harrison",
            "content": "FIGURE 444e-1 The molecular architecture of the myelin sheath illustrating the most important disease-related proteins. The illustration represents a composite of central nervous system (CNS) and peripheral nervous system (PNS) myelin. Proteins restricted to CNS myelin are shown in green, proteins of PNS myelin are lavender, and proteins present in both CNS and PNS are red. In the CNS, the X-linked allelic disorders, Pelizaeus-Merzbacher disease and one variant of familial spastic paraplegia, are caused by mutations in the gene for proteolipid protein (PLP) that normally promotes extracellular compaction between adjacent myelin lamellae. The homologue of PLP in the PNS is the P0 protein, mutations in which cause the neuropathy Charcot-Marie-Tooth disease (CMT) type 1B. The most common form of CMT is the 1A subtype caused by a duplication of the PMP22 gene; deletions in PMP22 are responsible for another inherited neuropathy termed hereditary liability to pressure palsies (Chap. 459)."
        },
        {
            "id": "Immunology_Janeway_394",
            "title": "Immunology_Janeway",
            "content": "2.5 Short Answer: One way in which the alternative pathway activates is by spontaneous hydrolysis of the C3 thioester bond that is normally used to covalently attach to the pathogen\u2019s surface. How can the alternative pathway proceed to form a membrane-attack complex if the C3 convertase that initiates this process is soluble? 2.6 Fill-in-the-Blanks: Paroxysmal nocturnal hemoglobinuria, a disease characterized by episodes of intravascular red blood cell lysis, is the result of red blood cells losing the expression of ________ and ________, which renders them susceptible to lysis by the ________ pathway of the complement system. 2.7 Matching: Match each of the following complement-regulatory proteins with the pathological manifestation that would develop if this factor were defective: A. C1INH 1. Atypical hemolytic uremic syndrome B. Factor H & factor I 2. Hereditary angioedema"
        },
        {
            "id": "Pathology_Robbins_1531",
            "title": "Pathology_Robbins",
            "content": "Since the CFTR gene was cloned in 1989, more than 1800 disease-causing mutations have been identified. They can be classified on the basis of clinical course of CF or the nature of the underlying defect. Mechanistically, they may result in reduced quantity of functional CFTR that reaches the cell surface or reduced function of CFTR that reaches the cell surface. As we shall see these differences impact on the development of treatment strategies. They can also be classified as severe or mild, depending on the clinical phenotype. Severe mutations are associated with complete loss of CFTR protein function, whereas mild mutations allow some residual function. The most common severe CFTR mutation is a deletion of three nucleotides coding for phenylalanine at amino acid position 508 (\u0394F508). This causes misfolding and total loss of the CFTR. Worldwide, \u0394F508 mutation is found in approximately 70% of patients with CF. Since CF is an autosomal recessive disease, affected persons harbor"
        },
        {
            "id": "Neurology_Adams_7794",
            "title": "Neurology_Adams",
            "content": "calcification) An adult case of this type was described by Fahr, so that his name is sometimes attached to this disorder. This is an idiopathic and sometimes familial form of calcification of the basal ganglia and cerebellum in which choreoathetosis and rigidity are prominent acquired features. The clinical state may also take the form of a parkinsonian syndrome or bilateral athetosis. In two of our patients there was unilateral choreoathetosis, which was replaced gradually by a parkinsonian syndrome, and in another of our sporadic cases, the initial abnormality was a unilateral dystonia responsive to l-dopa. Some patients have been developmentally delayed but most are intellectually normal. The serum calcium levels in the aforementioned diseases are usually normal and there is no explanation of the calcification. A mutation of SLC20A2, coding for a protein involved in phosphate transport, is responsible for half of instances and a smaller number are caused by mutations in the PDGFRB."
        },
        {
            "id": "InternalMed_Harrison_30591",
            "title": "InternalMed_Harrison",
            "content": "GLossary of prion terminoLoGy Prion Proteinaceous infectious particle that lacks nucleic acid. Prions are composed entirely of alternatively folded proteins that undergo self-propagation. Distinct strains of prions exhibit different biologic properties, which are epigenetically heritable. PrP prions cause scrapie in sheep and goats, mad cow disease, and related neurodegenerative diseases of humans such as Creutzfeldt-Jakob disease (CJD). PrPSc Disease-causing isoform of the prion protein. This protein is the only identifiable macromolecule in purified preparations of scrapie prions. PrPC Cellular isoform of the prion protein. PrPC is the precursor of PrPSc. PrP 27-30 A fragment of PrPSc, generated by truncation of the NH2terminus by limited digestion with proteinase K. PrP 27-30 retains prion infectivity and polymerizes into amyloid. PRNP PrP gene located on human chromosome 20."
        },
        {
            "id": "Biochemistry_Lippincott_757",
            "title": "Biochemistry_Lippinco",
            "content": "7.3. A 10-year-old boy was evaluated for burning sensations in his feet and clusters of small, red-purple spots on his skin. Laboratory studies revealed protein in his urine. Enzymatic analysis revealed a deficiency of \u03b1galactosidase, and enzyme replacement therapy was recommended. The most likely diagnosis is: A. Fabry disease. B. Farber disease. C. Gaucher disease. D. Krabbe disease. E. Niemann-Pick disease. Correct answer = A. Fabry disease, a deficiency of \u03b1-galactosidase, is the only X-linked sphingolipidosis. It is characterized by pain in the extremities, a red-purple skin rash (generalized angiokeratomas), and kidney and cardiac complications. Protein in his urine indicates kidney damage. Enzyme replacement therapy is available. 7.4. Current medical advice for individuals experiencing chest pain is to call emergency medical services and chew a regular strength, noncoated aspirin. What is the basis for recommending aspirin?"
        },
        {
            "id": "Immunology_Janeway_3180",
            "title": "Immunology_Janeway",
            "content": "caused by mutations in quite a different gene, that encoding the TNF\u03b1 receptor TNFRI. Patients with TRAPS have reduced levels of TNFRI, which lead to increased levels of proinflammatory TNF\u03b1 in the circulation because it is not regulated by binding to this receptor. The disease responds to therapeutic blockade with antiTNF agents such as etanercept, a soluble TNF receptor developed primarily to treat patients with rheumatoid arthritis (see Section 168). Mutations in the gene encoding PSTPIP1 (prolineserinethreonine phosphataseinteracting protein 1), which interacts with pyrin, are associated with another dominantly inherited autoinflammatory syndrome\u2014pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA). The mutations increase binding of pyrin to PSTPIP1, and it has been proposed that the interaction sequesters pyrin and limits its normal regulatory function."
        },
        {
            "id": "Neurology_Adams_11137",
            "title": "Neurology_Adams",
            "content": "distribution of certain structural proteins may alter the topography of disease expression; for example, the eye muscles do not contain dystrophin, a submembrane protein that is deficient in Duchenne muscular dystrophy, which explains the muscles\u2019 lack of involvement in this disease. The endomysial fibroblasts of eye muscles contain an abundance of glycosaminoglycans, which renders them susceptible to thyroid diseases. Diseases of the neuromuscular junction show a distribution of weakness in relation to the density of these junctions in different muscles. Doubtless other differences will be discovered."
        },
        {
            "id": "Biochemistry_Lippincott_1930",
            "title": "Biochemistry_Lippinco",
            "content": "Treatment: The ileus was successfully treated nonsurgically. For management of the CF, the family was referred to the CF center at the regional children\u2019s hospital. Prognosis: CF is the most common life-limiting autosomal-recessive disease in Caucasians. Case-Related Questions: Choose the ONE best answer. Q1. CF is the result of mutations to the gene that encodes the CF transmembrane conductance regulator (CFTR) protein that functions as a chloride channel in the apical membrane of epithelial cells on a mucosal surface. Which of the following statements concerning CF is correct? A. Clinical manifestations of CF are the consequence of chloride retention with increased water reabsorption that causes mucus on the epithelial surface to be excessively thick and sticky. B. Excessive pancreatic secretion of insulin in CF commonly results in hypoglycemia."
        },
        {
            "id": "Pathology_Robbins_1532",
            "title": "Pathology_Robbins",
            "content": "This causes misfolding and total loss of the CFTR. Worldwide, \u0394F508 mutation is found in approximately 70% of patients with CF. Since CF is an autosomal recessive disease, affected persons harbor mutations on both alleles. As discussed later, the nature of mutations on the two alleles influences the overall phenotype, as well as organ-specific manifestations. Although CF remains one of the best-known examples of the \u201cone gene\u2013one disease\u201d axiom, there is increasing evidence that other genes modify the frequency and severity of organ-specific manifestations. Examples of modifier genes include mannose-binding lectin 2 (MBL2) and transforming growth factor-\u03b21 (TGF\u03b21). It is postulated that polymorphisms in these genes influence the ability of the lungs to tolerate infections with virulent microbes (see later), thus modifying the natural history of CF."
        },
        {
            "id": "Neurology_Adams_10670",
            "title": "Neurology_Adams",
            "content": "M protein, and skin changes, mainly hypertrichosis and skin thickening). The same process has been referred to as the Crow-Fukase syndrome in Japan, where the disease is prevalent. In many cases there is lymphadenopathy attributable to the angiofollicular hyperplasia of Castleman disease. Another characteristic feature of the osteosclerotic-related polyneuropathy is a greatly elevated CSF protein."
        }
    ],
    "scores": [
        0.01913919413919414,
        0.017496229260935144,
        0.017494270435446907,
        0.016195109461016516,
        0.01505752312203925,
        0.014968082764692935,
        0.014338575393154487,
        0.013792776566499194,
        0.013729659763313608,
        0.011904761904761904,
        0.0115975935828877,
        0.011329113924050633,
        0.011199601791936287,
        0.010507446221731935,
        0.009900990099009901,
        0.009900990099009901,
        0.009900990099009901,
        0.009900990099009901,
        0.00980392156862745,
        0.00980392156862745,
        0.00980392156862745,
        0.009708737864077669,
        0.009708737864077669,
        0.009708737864077669,
        0.009708737864077669,
        0.009615384615384616,
        0.009615384615384616,
        0.009615384615384616,
        0.009523809523809525,
        0.009523809523809525,
        0.009523809523809525,
        0.009433962264150943
    ]
}